AlphaYouFI
Insider selling
Fady Ibraham Malik sold $215K of Cytokinetics Inc (CYTK) stock
Fady Ibraham Malik, EVP Research & Development of Cytokinetics Inc (CYTK), sold 3,500 shares of CYTK stock worth $215K, per an SEC Form 4 filed Oct 6, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on Oct 6, 2026.
- Traded
- Oct 6, 2026
- Disclosed
- Oct 6, 2026
- Filing delay
- 0 days
- Role
- EVP Research & Development
- Source
- SEC Form 4
More CYTK insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.